Turn Therapeutics Inc. Common Stock (TTRX) — Cash Flow-to-Debt Ratio
Turn Therapeutics Inc. Common Stock (TTRX) has a Cash Flow-to-Debt Ratio of -0.06x as of June 2026, meaning its operating cash flow of $-923.36K could theoretically repay 0% of its total liabilities ($16.27 Million) in one year. See TTRX FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Turn Therapeutics Inc. Common Stock Cash Flow-to-Debt Ratio (2023–2025)
Historical debt coverage capacity for Turn Therapeutics Inc. Common Stock across 3 annual periods. For the full cash flow conversion analysis, see Turn Therapeutics Inc. Common Stock (TTRX) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Turn Therapeutics Inc. Common Stock (2023–2025)
Year-by-year debt coverage analysis for Turn Therapeutics Inc. Common Stock. Check earnings quality score of Turn Therapeutics Inc. Common Stock to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.34x | $-2.56 Million | $7.48 Million | ▲ +43.9% |
| 2024 | -0.61x | $-1.36 Million | $2.23 Million | ▲ +14.4% |
| 2023 | -0.71x | $-1.38 Million | $1.93 Million | — |